Establishment of age- and sex-specific reference intervals for serum liver function tests in pediatric population

Xuetong Zhu1, Kaijin Wang1, Qi Zhou2

  • 1Department of Laboratory Medicine, First Hospital of Jilin University, Changchun, China.

Insights

Establishing accurate pediatric reference intervals (RIs) for liver function tests is crucial for diagnosing childhood diseases. This study determined age- and sex-specific RIs and analyzed analyte correlations in children.

Area of Science:

  • Clinical Chemistry
  • Pediatric Medicine
  • Biochemistry

Background:

  • Accurate reference intervals (RIs) are essential for diagnosing, treating, and determining the prognosis of pediatric diseases.
  • Establishing pediatric-specific RIs for liver function tests is critical for accurate clinical assessment in children.

Purpose of the Study:

  • To establish pediatric reference intervals (RIs) for key liver function tests.
  • To evaluate the dynamic changes and correlations among these liver function analytes in a pediatric population.

Main Methods:

  • Prospective recruitment of 6,322 children and adolescents (aged 1-18 years) in Jilin Province, China.
  • Analysis of liver function tests using an Ortho VITROS 5600 automatic biochemical analyzer.
  • Stratification by age and sex using regression tree and Harris and Boyd's methods; dynamic RI changes assessed by the lambda-mu-sigma method.

Main Results:

  • Significant age and sex differences observed in most liver function analytes, except serum total protein.
  • Specific trends identified: albumin, total protein, GGT, and bilirubin increased with age; AST decreased.
  • Strongest correlations found between total bilirubin and unconjugated bilirubin (r=0.788), and total bilirubin and albumin (r=0.511).

Conclusions:

  • Liver function test analytes exhibit unique age-dependent dynamic changes in the pediatric population.
  • Established age- and sex-specific pediatric RIs are necessary for accurate disease diagnosis.
  • Identified analyte correlations can guide future research and clinical interpretations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
130
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
81
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
104
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
146